Allergan Inc (AGN)

AGN (NYSE:Drugs)
$162.11
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | AGN Avg Daily Volume: 2,366,300
Last Update: 08/28/14 - 4:01 PM EDT
Volume: 0
YTD Performance: 45.94%
Open: $0.00
Previous Close: $162.11
52 Week Range: $86.95 - $174.49
Oustanding Shares: 297,183,809
Market Cap: 48,369,636,753
6-Month Chart
TheStreet Ratings Grade for AGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 6 6 7 7
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 2.23 2.23 2.29 2.29
Latest Dividend: 0.05
Latest Dividend Yield: 0.12%
Dividend Ex-Date: 08/13/14
Price Earnings Ratio: 37.33
Price Earnings Comparisons:
AGN Sector Avg. S&P 500
37.33 38.60 28.94
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
3.84% 84.32% 107.54%
GROWTH 12 Mo 3 Yr CAGR
Revenue 8.50 0.28 0.09
Net Income -10.30 258.69 5.26
EPS -9.80 0.00 0.00
Earnings for AGN:
EBITDA 2.07B
Revenue 6.30B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.47 $1.64 $5.79 $8.26
Number of Analysts 10 10 13 12
High Estimate $1.55 $1.70 $5.82 $8.37
Low Estimate $1.44 $1.53 $5.75 $7.74
Prior Year $1.23 $1.35 $4.77 $5.79
Growth Rate (Year over Year) 19.19% 21.70% 21.38% 42.63%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bullish
Aug 08, 2014 | 7:40 AM EDT
AGN was upgraded from Market Perform to Outperform, Leerink Swann said. Risk/reward is compelling, following a significant pullback in ...
Were Walgreen, Time Warner and Allergan too quick to dismiss the fast money?
We are now going to see a real test of the market's strength.
Bullish
Jul 22, 2014 | 8:21 AM EDT
AGN was upgraded from Neutral to Buy, UBS said. $200 price target. The company plans to see more sales growth, while they consider a de...
Bullish
Jul 22, 2014 | 7:21 AM EDT
Shares of AGN now seen reaching $184, according to Leerink Swann. Estimates also increased, as the company is aggressively cutting cost...
The consensus of positives is just too cute.
There are amazing cross currents that make fundamental security analysis hard.
Cheap money and greed from the Allergan bidder's side are strong incentives.
Here are several themes that are still working -- and now you can get in at a bargain.

Columnist Conversations

If this market has taught us one thing over the past 5 years, it has been to not be dogmatic in our views. Th...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market recovers a bit from early losses after European Bourses close at 11:30am EST. Upwardly revised Q2 GDP ...
When I do an article on a stock I do my best to define the risk on the trade. Sometimes I get to follow up an...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.